Injecto Polymers IPO Day 1: Subscribed 0.29x; QIBs lead with 1.02x

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Injecto Polymers IPO subscribed 0.29x on Day 1
  • QIB demand surged to 1.02x in late trading
  • Retail subscription reached 0.25x
  • Issue remains open until September 16, 2026
powered bylight_fuzz_icon
50659624

*this image is generated using AI for illustrative purposes only.

Injecto Polymers IPO subscription accelerated sharply on Day 4, reaching a total of 1.28x. Qualified Institutional Buyers (QIB) drove the momentum, jumping 53.9% intraday from 1.02x to 1.57x in the final hours. Retail investors also pushed their subscription above the fully subscribed mark to 1.26x.

Subscription Status

The Injecto Polymers IPO witnessed a significant surge in demand during the final hours of the bidding window on Day 4. While the first two days saw modest interest, Day 3 triggered a rise in NII and Retail bids, pushing the total to 0.91x. On Day 4, the issue gained further traction, crossing the 1x threshold early and closing at 1.28x.

Day Date QIB NII (bHNI) NII (sHNI) Retail Total
Day 1 11-09-2026 1.02x 0.03x 0.10x 0.25x 0.29x
Day 2 14-09-2026 1.02x 0.03x 0.10x 0.25x 0.29x
Day 3 15-09-2026 1.02x 0.09x 1.38x 0.84x 0.91x
Day 4 16-09-2026 1.57x 0.22x 1.70x 1.26x 1.28x

Intra-day Timeline

Subscription activity picked up pace sharply in the final hours of trading. The total subscription jumped from 0.09x at 14:15 PM to 0.29x by 17:15 PM, driven primarily by institutional investor interest and late retail bids.

Time (IST) QIB NII (bHNI) Retail Total
12:15 0.00x 0.02x 0.07x 0.04x
13:15 0.00x 0.02x 0.08x 0.06x
14:15 0.00x 0.02x 0.15x 0.09x
15:15 1.02x 0.02x 0.17x 0.25x
16:15 1.02x 0.03x 0.20x 0.27x
17:15 1.02x 0.03x 0.25x 0.29x

Category-wise Breakdown

Qualified Institutional Buyers (QIB) emerged as the strongest category by the end of Day 4, subscribing 1.57 times its quota after a late-day surge. Non-Institutional Buyers (NII) saw the bHNI segment subscribe 1.70 times its quota, while sHNI participation stood at 0.22x. Retail investors showed consistent improvement, rising from 0.25x on Day 1 to 1.26x on Day 4, crossing the fully subscribed threshold. Employee quota remained unsubscribed at 0x.

Offer Details

Injecto Polymers priced its IPO in the band of ₹98.00000 - ₹100.00000. The issue size ranges from ₹235200 to ₹500000. The minimum bid quantity is set at 2400 shares. The bidding window opened on 2026-09-11 and closed on 2026-09-16.

About the Company

Injecto Polymers Limited is a packaging company engaged in manufacturing diverse packaging products including Polypropylene Woven Fabrics, PP Woven Bags, BOPP bags, FIBC bags, and non-woven bags. The company also trades plastic granules and PVC resins. It operates two manufacturing units in West Bengal with a combined installed capacity of 18,070 MT. The company serves customers across agriculture, construction, textiles, chemicals, and consumer goods industries through a B2B model. Promoted by Ramesh Kumar Rateria and Ashok Kumar Rateria, the promoters bring 65 years of combined industry experience.

Financial Highlights

The company reported revenue from operations of ₹375.53 crores for FY26, up from ₹261.48 crores in FY25 and ₹109.05 crores in FY24. Profit before tax stood at ₹23.45 crores in FY26, compared to ₹11.20 crores in FY25 and ₹4.94 crores in FY24.

Metric FY24 FY25 FY26
Revenue from Operations (₹ crores) 109.05 261.48 375.53
Profit Before Tax (₹ crores) 4.94 11.20 23.45
Total Assets (₹ crores) 121.25 170.57 270.93

Objects of the Issue

The company plans to utilize the proceeds for the following purposes:

  • Funding Capital expenditure for Phase IV expansion at existing manufacturing facility: ₹30.50 crores
  • Repayment/pre-payment of certain outstanding borrowings: ₹10.00 crores
  • General Corporate Purposes: Balance proceeds

Risk Factors

  • High Customer Concentration: Top 10 customers contributed 40.07% of FY26 revenue.
  • Dependence on Trading Activities: Trading contributed 50.36% of FY26 revenue.
  • Geographic Concentration: 85.27% of FY26 revenue generated from West Bengal.
  • Raw Material Supply and Price Volatility: Dependency on polypropylene and other raw materials.
  • Negative Operating Cash Flows: Reported negative operating cash flows in FY24, FY25, and FY26.

What's Next

Allotment is scheduled for 2026-09-17. The shares are expected to list on 2026-09-21.

Will the late-day surge in QIB demand sustain through the remaining bidding days, or is it indicative of price-sensitive institutional interest?

How might Injecto Polymers' heavy reliance on trading activities (over 50% of revenue) impact investor confidence in its long-term manufacturing growth story?

Given the negative operating cash flows over the last three years, how will investors assess the company's ability to service debt post-IPO despite the proposed repayment of ₹10 crores?

like15
dislike